![Steven R. Arikian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven R. Arikian
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Douglas Calder | M | 56 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 6 Jahre |
Christopher Chapman | M | 71 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 5 Jahre |
Garrison Hasara | M | 54 | 10 Jahre | |
Frank O'Donnell | M | 74 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 10 Jahre |
William S. Poole | M | 77 | - | |
John Sitilides | M | 61 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Martin G. Baum | M | 57 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Priya Jambhekar | F | - | 3 Jahre | |
Alan M. Pearce | M | 75 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 6 Jahre |
Edmund King | M | 89 | 7 Jahre | |
Laurie Glimcher | M | 72 | 20 Jahre | |
Brian Bottjer | M | 50 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
David Schubert | M | 57 | - | |
Angelos Stergiou | M | 48 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 Jahre |
Ronald Osman | M | 78 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Charles Sigal | M | 72 | 16 Jahre | |
Raphael J. Mannino | M | 77 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Jeffrey Scott | M | 67 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Samuel Duffey | M | 78 | 10 Jahre | |
Anthony Hooper | M | 69 | 15 Jahre | |
Gerald Crabtree | M | 83 | 7 Jahre | |
James Sapirstein | M | 63 | 4 Jahre | |
Robert Roche | M | 57 | 6 Jahre | |
David Ian Johnson | M | 66 | 12 Jahre | |
Michael Tardugno | M | 73 | 2 Jahre | |
Todd D. Thomason | M | 56 | - | |
Peter S. Linsley | M | 72 | 14 Jahre | |
Joachim von Roy | M | 79 | - | |
Lie Ping Chen | M | - | - | |
James A. Wachholz | M | 70 | 2 Jahre | |
James E. Shiah | M | 64 | 3 Jahre | |
Elliott Levy | M | 65 | 17 Jahre | |
Kenneth Anderson | M | - | 17 Jahre | |
Mark Reisenauer | M | 58 | 2 Jahre | |
Robert W. Morrissey | M | 66 | 6 Jahre | |
Brian Crynes | M | 77 | 3 Jahre | |
Dion Sullivan | M | - | 6 Jahre | |
Paul von Autenried | M | 62 | 26 Jahre | |
Douglas C. Plessinger | M | 55 | 6 Jahre | |
Wenqing Yao | M | 61 | 6 Jahre | |
Donald Handley | M | - | 3 Jahre | |
Lucius Allen | M | - | - | |
William C. Reynolds | M | - | 7 Jahre | |
Gary Dickinson | M | 72 | 4 Jahre | |
Cheryl Capps | F | 62 | 13 Jahre | |
Larry K. Benedict | M | 63 | 7 Jahre | |
Laurie Alsup | M | 70 | 10 Jahre | |
Dmitry Borisovich Syromyatnikov | M | - | 7 Jahre | |
Julie Smith | F | 53 | - | |
Beth Anne Piper | M | - | 4 Jahre | |
Jarrett Disbrow | M | 49 | 4 Jahre | |
Mike Werner | M | - | 4 Jahre | |
A. Collier Smyth | M | 78 | 13 Jahre | |
Jonathan Mow | M | 59 | 2 Jahre | |
Steven J. Stogel | M | - | - | |
Barry A. Labinger | M | 60 | 3 Jahre | |
Carl Ray Holman | M | 82 | - | |
Helen Torley | M | 61 | 5 Jahre | |
Geoffrey Gilmore | M | 58 | 11 Jahre | |
Kevin Rooney | M | 58 | 6 Jahre | |
Michael A. Popson | M | - | 6 Jahre | |
R. Scott Jones | M | 66 | 2 Jahre | |
David K. Bol | M | 58 | 6 Jahre | |
James R. Ellinghausen | M | 65 | 8 Jahre | |
Luigi Lenaz | M | 83 | 19 Jahre | |
Bob Daniel Weiss | M | 72 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 Jahre |
Sam Owusu-Akyaw | M | 71 | 2 Jahre | |
Nicholas J. Leb | M | - |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
James T. Crines | M | 64 | 2 Jahre | |
Stephane Allard | M | 70 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 1 Jahre |
Timothy P. Cost | M | 65 | 5 Jahre | |
Gregg L. Bienstock | M | 59 | 1 Jahre | |
Christine Poon | F | 71 | 3 Jahre | |
Carl M. Cohen | M | 76 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | - |
Marino Carol | F | - | 8 Jahre | |
Michael Loberg | M | 76 | 18 Jahre | |
David Redmond | M | 72 | 1 Jahre | |
Richard J. White | M | 82 | 12 Jahre | |
Rick Winningham | M | 64 | 4 Jahre | |
Matthew Wikler | M | 74 | 4 Jahre | |
Dennis L. Ryll | M | - | - | |
Hank Safferstein | M | - | 3 Jahre | |
Adeoye Olukotun | M | 79 | 13 Jahre | |
Jaisim Shah | M | 63 | 3 Jahre | |
James McNulty | M | 73 |
BioVest International, Inc.
![]() BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | 4 Jahre |
N. Coles | M | 63 | - | |
Mark E. McGovern | M | 70 | 11 Jahre | |
Giorgio Mosconi | M | 63 | 4 Jahre | |
Leon E. Rosenberg | M | 90 | 1 Jahre | |
John P. Dubinsky | M | 80 | 3 Jahre | |
William A. Scott | M | 84 | 6 Jahre | |
Nicole Onetto | M | 71 | 6 Jahre | |
Myrtle Potter | F | 65 | 4 Jahre | |
Emmanuel Blin | M | 54 | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 94 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Steven R. Arikian
- Persönliches Netzwerk